Gamida Cell Ltd [NASDAQ: GMDA] stock went on a downward path that fall over -18.25% on Friday, amounting to a one-week price decrease of less than -9.42%. The company report on April 1, 2024 at 8:00 AM that Aquestive Therapeutics Strengthens Board of Directors with
Gamida Cell Ltd [NASDAQ: GMDA] closed the trading session at $0.04. The company report on March 27, 2024 at 7:00 AM that Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management. Company expected to receive significant new capital from Highbridge to bolster
Gamida Cell Ltd [NASDAQ: GMDA] loss -82.74% or -0.28 points to close at $0.06 with a heavy trading volume of 122958035 shares. The company report on March 27, 2024 at 7:00 AM that Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management.
Gamida Cell Ltd [NASDAQ: GMDA] surged by $0.05 during the normal trading session on while it closed the day at $0.37. Gamida Cell Ltd stock has also gained 8.82% of its value over the past 7 days. However, GMDA stock has inclined by 27.59% in
Gamida Cell Ltd [NASDAQ: GMDA] closed the trading session at $0.46. The company report on January 29, 2024 at 6:00 AM that Gamida Cell Actively Pursuing Strategic Alternatives. While pursuing strategic alternatives, the company continues to put its focus and resources behind the commercialization of
© 2024, Powered by Smart TechOne
